Skip to main content
Smart Investors Daily
Scopus BioPharma Inc. logo

OTC · SCPS

Scopus BioPharma Inc.

Healthcare · Biotechnology

$0.00

Down-$0.00 (-33.33%)

Updated Oct 7, 2026, 12:59 PM

SID Score

3.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
16.09K
P/E ratio
-0
Dividend yield
0.00%
52-week range
$0.00 – $0.01
Volume
1K
Avg. volume
2.25K

Price performance · SCPS

SCPS price history

1M range · 9 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

SCPS closed at $0.00 after 9 trading sessions, up 0.00% for the selected period.

Last close
$0.00
Period change
+0.00%
Period low
$0.00
Period high
$0.00
Daily close
View OHLC price history
SCPS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$0.0004$0.0004$0.0004$0.00041K
Oct 5, 2026$0.0006$0.0006$0.0006$0.0006269
Oct 2, 2026$0.0004$0.0004$0.0004$0.00042K
Oct 1, 2026$0.0004$0.0004$0.0004$0.0004501
Sep 30, 2026$0.0004$0.0004$0.0004$0.0004448
Sep 23, 2026$0.0004$0.0004$0.0004$0.000432.05K
Sep 14, 2026$0.0006$0.0006$0.0006$0.00065K
Sep 11, 2026$0.0006$0.0006$0.0006$0.00062.82K
Sep 10, 2026$0.0004$0.0004$0.0004$0.0004500

Latest SCPS news

The latest Smart Investors Daily articles mentioning SCPS.

SCPS research

Overview

Company profile and research snapshot.

Company profile

SCOPUS BIOPHARMA INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$12.24
Implied upside
—
Analysts
—
SCPS recent ratings
DateFirmRatingTarget
Feb 16, 2021BenchmarkSpeculative Buy—
Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Dec 10, 2025

Contrasting Scopus BioPharma (NASDAQ:SCPS) & MorphoSys (NASDAQ:MOR)

Institutional and Insider Ownership 18.4% of MorphoSys shares are held by institutional investors. 0.1% of MorphoSys shares are held by insiders. Comparatively, 5.1% of Scopus BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.